Back

Hyperkalemia, clinical outcomes, and mineralocorticoid receptor antagonist in heart failure: insights from the REVIEW-HF registry

9 May 2026 (11:30 - 12:15)
Organised by: Logo
Congress Presentation Part of: Epidemiology and temporal trends of heart failure Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Jumpei Aoki

Toho University Omori Medical Center, Tokyo (Japan)

6 More presentations in this session

Presentation thumbnail
Reproductive patterns and heart failure risk: insights from five aggregated cohorts
Ms E. Shalowitz (Aurora, US)
Abstract Slides
Presentation thumbnail
Health disparities in heart failure with reduced ejection fraction among immigrants in Sweden: data from the Swedish Heart Failure Registry
Doctor V. Valente (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Prognostic utility of the kansas city cardiomyopathy questionnaire across cognitive function levels in older patients with heart failure: insights from the JROADHF-NEXT registry
Doctor T. Nakade (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Association of patient-centred remote monitoring with clinical outcomes in previously hospitalised patients: the TELESAT-PRIOR-HF study
Doctor L. Monzo (Vandoeuvre-Les-Nancy, FR)
Abstract Slides Video
Presentation thumbnail
Early data from a heart failure virtual ward programme: clinical and financial considerations
Doctor G. Bruno (Limerick, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Epidemiology and temporal trends of heart failure

The Event

Event poster

Heart Failure 2026

9 May 2026 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Initiation of mineralocorticoid receptor antagonists in patients with cardiorenal diseases: potassium changes, hyperkalaemia risk and discontinuation in the CaRe study
thumbnail
Congress Presentation
Real-world use and effectiveness of patiromer among patients with heart failure at high risk of hyperkalaemia: insights from the CARE-HK in HF registry
thumbnail
Congress Presentation
Hypokalaemia during decongestion with hydrochlorothiazide: the CLOROTIC Trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources